MedTrace Logo

Early Abduction Splintage on Stable Hips in Infants With Developmental Dysplasia of the Hip

NCT02885831 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2019-04-12

No results posted yet for this study

Summary

The aim of this study is to prove the improvement of pubo-femoral distance by early abduction splintage in one-month-old infants with developmental dysplasia of the hip (with a clinical stable hip but an abnormal hip ultrasonography).

Conditions

  • Congenital Hip Dysplasia

Interventions

DEVICE

Abduction splintage

Treatment by abduction splintage 24 hours a day and 7 days a week, for 2 months.

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Matthias THEPAUT, PhD · University Hospital, Brest

Eligibility

Min Age
1 Month
Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-08
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02885831 on ClinicalTrials.gov